This Month in The Journal

As genetic sequencing becomes more commonplace and  genomic datasets are assembled, there is growing interest in giving research participants access to clinically relevant secondary findings. Recommendations for the return of these findings in the clinical setting are largely formed at this point and are typically based on the ACMG’s list of g enes in which a set of variants is known to cause disease. However, consensus related to the return of these findings outside of a clinical setting is still evolving.

Source: The American Journal of Human Genetics - September 6, 2018 Category: Genetics & Stem Cells Authors: Sarah Ratzel, Sara B. Cullinan Tags: Editors' Corner Source Type: research